Milan: Philogen well in the green
(Teleborsa) - A positive session for the developer of biopharmaceutical products for the treatment of life-threatening conditions as it progresses +1.9%
Looking at the weekly scenario, Philogen lagged the benchmark index's gains, showing a lower performance than the FTSE Italia Mid Cap average.
The short-term scenario shows a decline towards the 18.75 Euros area with first resistance seen at 18.75. Expectations are for Philogen to continue its negative run towards support at 18.75.
These analyses are to be considered solely for information purposes and are not in any way intended to constitute financial advice, a solicitation of funds from the public or the promotion of any form of investment.
(Teleborsa Research Department)
(Teleborsa) 01-06-2025 09:35 AM
Looking at the weekly scenario, Philogen lagged the benchmark index's gains, showing a lower performance than the FTSE Italia Mid Cap average.
The short-term scenario shows a decline towards the 18.75 Euros area with first resistance seen at 18.75. Expectations are for Philogen to continue its negative run towards support at 18.75.
These analyses are to be considered solely for information purposes and are not in any way intended to constitute financial advice, a solicitation of funds from the public or the promotion of any form of investment.
(Teleborsa Research Department)
(Teleborsa) 01-06-2025 09:35 AM